← Back to headlines
Citi Lifts Novo Nordisk Target on GLP-1 Pill Launch
Citi has raised its target for Novo Nordisk following the strong launch of the company's GLP-1 pill, indicating positive market reception.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
